Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children's hospital

Pediatr Infect Dis J. 2013 Apr;32(4):346-9. doi: 10.1097/INF.0b013e31827ee1c2.

Abstract

Background: Use of outpatient parenteral antimicrobial therapy (OPAT) in pediatrics is widespread and may be increasing. Recent data quantifying use and characteristics of pediatric OPAT are lacking.

Methods: To evaluate the number of children receiving OPAT each year and their associated characteristics and outcomes, we conducted a retrospective review of all patients discharged with OPAT from the Mayo Clinic Children's Hospital between August 1, 2010 and December 31, 2011.

Results: During the study period, there were 126 pediatric hospital discharges with OPAT (2.5% of all discharges). OPAT was used most commonly to treat bone and joint (21%), bloodstream (15%), intra-abdominal (13%) and soft tissue (9%) infections. A positive culture or serology result was found in 86 (68%) OPAT courses. The most frequently used antibiotics were ceftriaxone (17%), cefazolin (16%) and cefepime (13%). The median duration of OPAT was 12 days. Thirty-six courses (29%) resulted in catheter- or antibiotic-associated complications. Weekly laboratory monitoring was more common when OPAT was managed by the infectious disease service (88%) versus other services (20%). Among 123 courses with follow-up, 109 (89%) resulted in cure, and 13 (11%) were treatment failures.

Conclusion: At our children's hospital, 2.5% of hospitalized patients were discharged with OPAT. In one-third of OPAT courses children developed catheter- or antibiotic-associated complications. Opportunities to increase the role of pediatric infectious disease in OPAT initiation and management should be explored.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intravenous / adverse effects
  • Adolescent
  • Ambulatory Care / methods*
  • Ambulatory Care Facilities
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Catheter-Related Infections / epidemiology
  • Child
  • Child, Preschool
  • Drug-Related Side Effects and Adverse Reactions / epidemiology
  • Female
  • Hospitals, Pediatric
  • Hospitals, University
  • Humans
  • Infant
  • Male
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Bacterial Agents